PZFVX
Price
$25.55
Change
+$0.06 (+0.24%)
Updated
Jul 3 closing price
Net Assets
626.85M
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

PZFVX vs VIVAX

Header iconPZFVX vs VIVAX Comparison
Open Charts PZFVX vs VIVAXBanner chart's image
JHancock Classic Value A
Price$25.55
Change+$0.06 (+0.24%)
VolumeN/A
Net Assets626.85M
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
PZFVX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PZFVX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PZFVX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. PZFVX (627M). PZFVX pays higher dividends than VIVAX: PZFVX (2.55) vs VIVAX (2.06). PZFVX was incepted earlier than VIVAX: PZFVX (29 years) vs VIVAX (33 years). PZFVX (1.16) is less costly to investors than VIVAX (0.17). PZFVX is a more actively managed with annual turnover of: 29.00 vs. VIVAX (9.00). PZFVX has a lower initial minimum investment than VIVAX: PZFVX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. PZFVX (-23.90). VIVAX return over 5 years is better than : 80.14 vs. PZFVX (16.46).
PZFVXVIVAXPZFVX / VIVAX
Total Expense Ratio1.150.17676%
Annual Report Gross Expense Ratio1.160.17682%
Fund Existence29 years33 years-
Gain YTD8.5396.209138%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets627M189B0%
Annual Yield % from dividends2.552.06124%
Returns for 1 year-23.9012.04-199%
Returns for 3 years-25.8235.16-73%
Returns for 5 years16.4680.1421%
Returns for 10 years6.14115.745%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.